SCHEMBL5207646

SCHEMBL5207646

O=c1[nH]c(S)ncc1Oc1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.41
LTA4H P09960 2/20 0.40
HAO1 Q9UJM8 2/20 0.38
CDK8 P49336 5/20 0.38
CCNC P24863 4/20 0.38
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
DAO P14920 1/20 0.37
PIM1 P11309 1/20 0.37
MAP2K2 P36507 1/20 0.37
MAP4K2 Q12851 1/20 0.37
MEN1 O00255 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
PLA2G1B P04054 1/20 0.36
POLB P06746 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202998 0.81 LTA4H (0.57) KDM4CLTA4HHAO1CDK8CCNC
SCHEMBL7716750 0.78 KDM4C (0.40) KDM4CLTA4HHAO1CDK8CCNC
SCHEMBL7708436 0.78 LMNA (0.52) KDM4CLTA4HHAO1CDK8CCNC
SCHEMBL7714271 0.72 P2RX3 (0.44) HTTLMNAPOLBCYP1A2MAPT
SCHEMBL7712513 0.72 HRH4 (0.49) CDK8CCNCMEN1KMT2APOLB
SCHEMBL7716633 0.72 KMT2A (0.49) LTA4HCDK8CCNCMEN1HPGD
SCHEMBL5204396 0.71 PTGS1 (0.43) KDM4CHAO1CDK8CCNCCCNT1
SCHEMBL6168942 0.71 RECQL (0.53) MEN1HPGDKMT2AHTTLMNA
SCHEMBL5206665 0.69 PTGS1 (0.33) KDM4CLTA4HCDK8CCNCPTGS1
SCHEMBL5206672 0.69 PTGS1 (0.33) KDM4CLTA4HCDK8CCNCPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed